Methylprednisolone and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Basaglar (insulin glargine). Common drug interactions include abdominal abscess among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Basaglar. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Aug, 04, 2026

24 people who take Methylprednisolone and Basaglar together, and have interactions are studied.

Methylprednisolone and Basaglar drug interactions.

What are the common drug interactions of Methylprednisolone and Basaglar, by gender? *:

female:

Abdominal abscess (collection of pus in abdomen)
Hyperglycaemia (high blood sugar)
Sepsis (a severe blood infection that can lead to organ failure and death)
Pneumonia
Chronic kidney disease
Febrile neutropenia (fever with reduced white blood cells)
Transplant rejection (a transplant material is not worked)
Breast cancer metastatic
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

Back pain
Arthralgia (joint pain)
Bone density decreased
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Decreased activity
Depression
Disability
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Drug hypersensitivity
Drug ineffective

What are the common drug interactions of Methylprednisolone and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

40-49:

n/a

50-59:

Abdominal abscess (collection of pus in abdomen)
Sepsis (a severe blood infection that can lead to organ failure and death)
Febrile neutropenia (fever with reduced white blood cells)
Transplant rejection (a transplant material is not worked)
Hyperglycaemia (high blood sugar)
Breast cancer metastatic
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Pneumonia
Spinal compression fracture (fracture due to spinal compression on bone)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

60+:

Chest discomfort
Cold sweat
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased
Pneumonia
Respiratory rate increased (excess breathing rate/min)
Restlessness (not able to rest)
Sneezing
Throat tightness
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

Pain: 4 people, 16.67%
Transplant Rejection (a transplant material is not worked): 3 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 8.33%
Infection: 2 people, 8.33%
Immunodeficiency Disorders: 2 people, 8.33%
Hiv Infection: 2 people, 8.33%
High Blood Cholesterol: 2 people, 8.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously